Valeant Pharmaceuticals reported $23.17B in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Amgen AMGN:US $ 36854M 3545M
Ani Pharmaceuticals ANIP:US $ 287.16M 0.21M
Aurora Cannabis Inc ACB:CN 388.14M 26.31M
Biogen BIIB:US $ 7275.2M 2.1M
Bristol Myers Squibb BMY:US $ 44972M 419M
Canopy Growth Corp WEED:CN C$ 1.5B 152.36M
Catalent CTLT:US $ 4186M 34M
Corcept Therapeutics CORT:US $ 0M 0M
Danaher DHR:US $ 21778M 398M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Endo International Ordinary Shares ENDP:US $ 8090.62M 183.92M
Gilead Sciences GILD:US $ 26208M 487M
Horizon Pharma HZNP:US $ 2568.74M 2.49M
JAZZ PHA JAZZ:US $ 6023.87M 32.75M
Lannett LCI:US $ 610.08M 6.6M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 923.42M 125.81M
Perrigo Ordinary Shares PRGO:US $ 3515.2M 5.3M
Phibro Animal Health PAHC:US $ 415.62M 15.18M
Prestige Brands PBH:US $ 1483.91M 53.86M
Revance Therapeutics RVNC:US $ 449.74M 169.1M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Valeant Pharmaceuticals VRX:CN $ 23168M 514M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Zoetis ZTS:US $ 6578M 14M